Browsing byAuthorWich, PR

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 6 of 6
Issue DateTitleAuthor(s)
-Attenuation of Cigarette-Smoke-Induced Oxidative Stress, Senescence, and Inflammation by Berberine-Loaded Liquid Crystalline Nanoparticles: In Vitro Study in 16HBE and RAW264.7 CellsPaudel, KR; Panth, N; Manandhar, B; Singh, SK; Gupta, G; Wich, PR; Nammi, S; MacLoughlin, R; Adams, J; Warkiani, ME; Chellappan, DK; Oliver, BG; Hansbro, PM; Dua, K
-Cellular signalling pathways mediating the pathogenesis of chronic inflammatory respiratory diseases: an updateMehta, M; Dhanjal, DS; Paudel, KR; Singh, B; Gupta, G; Rajeshkumar, S; Thangavelu, L; Tambuwala, MM; Bakshi, HA; Chellappan, DK; Pandey, P; Dureja, H; Charbe, NB; Singh, SK; Shukla, SD; Nammi, S; Aljabali, AA; Wich, PR; Hansbro, PM; Satija, S; Dua, K
2020-05-04Plants derived therapeutic strategies targeting chronic respiratory diseases: Chemical and immunological perspective.Prasher, P; Sharma, M; Mehta, M; Paudel, KR; Satija, S; Chellappan, DK; Dureja, H; Gupta, G; Tambuwala, MM; Negi, P; Wich, PR; Hansbro, NG; Hansbro, PM; Dua, K
2021-08Recent trends of NFκB decoy oligodeoxynucleotide-based nanotherapeutics in lung diseasesMehta, M; Paudel, KR; Shukla, SD; Allam, VSRR; Kannaujiya, VK; Panth, N; Das, A; Parihar, VK; Chakraborty, A; Ali, MK; Jha, NK; Xenaki, D; Su, QP; Wich, PR; Adams, J; Hansbro, PM; Chellappan, DK; Oliver, BGG; Dua, K
2020-09-24Targeting respiratory diseases using miRNA inhibitor based nanotherapeutics: Current status and future perspectives.Mehta, M; Satija, S; Paudel, KR; Malyla, V; Kannaujiya, VK; Chellappan, DK; Bebawy, M; Hansbro, PM; Wich, PR; Dua, K
-Treatment of chronic airway diseases using nutraceuticals: Mechanistic insightAllam, VSRR; Chellappan, DK; Jha, NK; Shastri, MD; Gupta, G; Shukla, SD; Singh, SK; Sunkara, K; Chitranshi, N; Gupta, V; Wich, PR; MacLoughlin, R; Oliver, BGG; Wernersson, S; Pejler, G; Dua, K